Not Yet RecruitingNot Applicable

CP382 - Intermittent Catheter (IC) PRO Panel Plan

1,000 participantsStarted 2026-03-12

Plain-language summary

The aim is to create an electronic patient reported outcome (e-PRO) based registry, specifically for subjects using an intermittent catheter as their primary bladder emptying method.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Willing to give informed consent * 18 years of age or above * Full legal capacity * Willing and able (self-assessed) to complete online questionnaires * using intermittent catheterization as the primary method for bladder emptying

What they're measuring

Number of IC products used by subjects.

Timeframe: 5 years

The number of urinary tract infections

Timeframe: 5 years

The Mental well-being index (WHO-5)

Timeframe: 5 years

Trial details

NCT IDNCT07475468

SponsorColoplast A/S

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2032-09-30

Contact for this trial

Carri Browne. Clinical Project Manager, BS

6123235772 dkcarr@coloplast.com

View on ClinicalTrials.gov More Intermittent Catheterization trials